Your search returned 4 results.

Results
	1.	Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors. [electronic resource] by Cohen, Leonard A Marks, Paul A Rifkind, Richard A Amin, Shantu Desai, Dhimant Pittman, Brian Richon, Victoria M Producer: 20020913 In: Anticancer research vol. 22 Availability: No items available. Save to lists Add to cart (remove)
	2.	The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. [electronic resource] by Butler, Lisa M Zhou, Xianbo Xu, Wei-Sheng Scher, Howard I Rifkind, Richard A Marks, Paul A Richon, Victoria M Producer: 20020927 In: Proceedings of the National Academy of Sciences of the United States of America vol. 99 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro. [electronic resource] by Kutko, Martha C Glick, Richard D Butler, Lisa M Coffey, Dennis C Rifkind, Richard A Marks, Paul A Richon, Victoria M LaQuaglia, Michael P Producer: 20040817 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 9 Availability: No items available. Save to lists Add to cart (remove)
	4.	Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation. [electronic resource] by Marrocco, Deborah L Tilley, Wayne D Bianco-Miotto, Tina Evdokiou, Andreas Scher, Howard I Rifkind, Richard A Marks, Paul A Richon, Victoria M Butler, Lisa M Producer: 20070316 In: Molecular cancer therapeutics vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)